Stay updated with breaking news from Nasdaq Cgem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $40.00 price objective on the stock. Several other brokerages have also weighed in on CGEM. HC Wainwright decreased their price objective on Cullinan Oncology […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) insider Corrine Savill sold 40,000 shares of the firm’s stock in a transaction dated Monday, January 29th. The shares were sold at an average price of $14.09, for a total transaction of $563,600.00. Following the transaction, the insider now directly owns 165,990 shares in the company, valued […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CEO Nadim Ahmed sold 4,272 shares of Cullinan Oncology stock in a transaction dated Tuesday, December 26th. The stock was sold at an average price of $9.24, for a total value of $39,473.28. Following the sale, the chief executive officer now directly owns 111,550 shares of the […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) insider Jeffrey Alan Jones sold 1,860 shares of the business’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $8.50, for a total value of $15,810.00. Following the sale, the insider now directly owns 56,191 shares of the company’s […]
Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) CFO Jeffrey Trigilio sold 1,920 shares of the company’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $8.50, for a total transaction of $16,320.00. Following the completion of the sale, the chief financial officer now directly owns 83,919 […]